NO20033318D0 - 2H-1-benzopyranderivater, fremgangsmåte ved fremstilling samt farmasöytiskesammensetninger derav - Google Patents

2H-1-benzopyranderivater, fremgangsmåte ved fremstilling samt farmasöytiskesammensetninger derav

Info

Publication number: NO20033318D0
Authority: NO; Norway
Prior art keywords: pharmaceutical compositions; manufacture; benzopyran derivatives; preparation; benzopyran
Prior art date: 2001-01-24

Application number

NO20033318A

Other languages

English (en)

Other versions

NO20033318L (no

NO327808B1 (no

Inventor

Maurizio Delcanale

Gabriele Amari

Elisabetta Armani

Maurizio Civelli

Elisabetta Galbiati

Original Assignee

Chiesi Farma Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-01-24

Filing date

2003-07-23

Publication date

2003-07-23

2001-01-24 Priority claimed from EP01101521A external-priority patent/EP1229036B1/en

2001-08-03 Priority claimed from EP01118682A external-priority patent/EP1281710A1/en

2003-07-23 Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa

2003-07-23 Publication of NO20033318D0 publication Critical patent/NO20033318D0/no

2003-09-24 Publication of NO20033318L publication Critical patent/NO20033318L/no

2009-09-28 Publication of NO327808B1 publication Critical patent/NO327808B1/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4

NO20033318A 2001-01-24 2003-07-23 2H-1-benzopyranderivater, fremgangsmate ved fremstilling samt farmasoytiske sammensetninger derav NO327808B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP01101521A EP1229036B1 (en)	2001-01-24	2001-01-24	2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
EP01118682A EP1281710A1 (en)	2001-08-03	2001-08-03	2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
PCT/EP2002/000567 WO2002059113A1 (en)	2001-01-24	2002-01-21	2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof

Publications (3)

Publication Number	Publication Date
NO20033318D0 true NO20033318D0 (no)	2003-07-23
NO20033318L NO20033318L (no)	2003-09-24
NO327808B1 NO327808B1 (no)	2009-09-28

Family

ID=26076450

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20033318A NO327808B1 (no)	2001-01-24	2003-07-23	2H-1-benzopyranderivater, fremgangsmate ved fremstilling samt farmasoytiske sammensetninger derav

Country Status (27)

Country	Link
US (1)	US6951883B2 (no)
EP (1)	EP1355906B1 (no)
JP (1)	JP4332349B2 (no)
CN (1)	CN1261431C (no)
AT (1)	ATE286894T1 (no)
AU (1)	AU2002237282B2 (no)
BR (1)	BR0207066A (no)
CA (1)	CA2435775A1 (no)
CZ (1)	CZ20032014A3 (no)
DE (1)	DE60202590T2 (no)
DK (1)	DK1355906T3 (no)
DZ (1)	DZ3459A1 (no)
EA (1)	EA006158B1 (no)
ES (1)	ES2236485T3 (no)
HK (1)	HK1060558A1 (no)
HU (1)	HUP0401018A3 (no)
IL (2)	IL157065A0 (no)
MA (1)	MA26982A1 (no)
MX (1)	MXPA03006505A (no)
NO (1)	NO327808B1 (no)
NZ (1)	NZ527144A (no)
PL (1)	PL365062A1 (no)
PT (1)	PT1355906E (no)
SI (1)	SI1355906T1 (no)
SK (1)	SK287086B6 (no)
TN (1)	TNSN03043A1 (no)
WO (1)	WO2002059113A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2407462B1 (en)	2004-09-21	2014-07-30	Marshall Edwards, Inc.	Substituted chroman derivatives, medicaments and use in therapy
JP4976649B2 (ja) *	2004-09-21	2012-07-18	マーシャルエドワーズ，インク．	化合物
US8080675B2 (en)	2004-09-21	2011-12-20	Marshall Edwards, Inc.	Chroman derivatives, medicaments and use in therapy
ES2377073T3 (es) *	2004-09-21	2012-03-22	Marshall Edwards, Inc.	Derivados de cromano sustituidos, medicamentos y utilización en terapia
WO2006032086A1 (en) *	2004-09-21	2006-03-30	Novogen Research Pty Ltd	Chroman derivatives, medicaments and use in therapy
AU2005201855B2 (en) *	2004-09-21	2012-03-29	Marshall Edwards, Inc.	Chroman derived compounds and formulations thereof for use in therapy
CN101444499B (zh) *	2007-11-26	2012-12-05	湘北威尔曼制药股份有限公司	一种化合物及其组合物的新用途
CA2816322A1 (en)	2010-11-01	2012-05-10	Marshall Edwards, Inc.	Isoflavonoid compositions and methods for the treatment of cancer
WO2014205138A1 (en)	2013-06-19	2014-12-24	Seragon Pharmaceuticals, Inc.	Estrogen receptor modulator and uses thereof
CA2974123C (en)	2015-02-02	2023-08-01	Mei Pharma, Inc.	Combination of benzopyran derivative and glycolytic inhibitors for cancer therapy
AU2017362460B2 (en) *	2016-11-17	2021-07-22	Sanofi	Novel substituted N-(3-fluoropropyl)-pyrrolidine compounds, processes for their preparation and therapeutic uses thereof
WO2019051562A1 (en) *	2017-09-15	2019-03-21	Norbio No. 1 Pty Ltd	TREATMENT OF EXCITOTOXICITY
CN112225716A (zh) *	2020-10-30	2021-01-15	陕西嘉禾生物科技股份有限公司	一种鹰嘴豆牙素a的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3374245A (en) *	1964-04-01	1968-03-19	Ciba Geigy Corp	Unsaturated oxacycles
DE1518002C3 (de) *	1965-01-02	1975-01-23	Merck Patent Gmbh, 6100 Darmstadt	Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel
US5280040A (en)	1993-03-11	1994-01-18	Zymogenetics, Inc.	Methods for reducing bone loss using centchroman derivatives
EP0937059A1 (en)	1996-10-28	1999-08-25	Novo Nordisk A/S	NOVEL $i(TRANS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
US5985306A (en)	1996-10-28	1999-11-16	Novo Nordisk A/S	(+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
US6153768A (en) *	1996-12-13	2000-11-28	C & C Research Laboratories	Benzopyran derivatives
KR20000001793A (ko) *	1998-06-13	2000-01-15	이경하	신규한 벤조피란 또는 티오벤조피란 유도체
DE69910830T2 (de)	1998-12-30	2004-06-17	Signal Pharmaceutical, Inc., San Diego	Verbindungen und verfahren zur modulation von estrogen rezeptoren

2002
- 2002-01-21 AT AT02703564T patent/ATE286894T1/de not_active IP Right Cessation
- 2002-01-21 EA EA200300727A patent/EA006158B1/ru not_active IP Right Cessation
- 2002-01-21 US US10/466,118 patent/US6951883B2/en not_active Expired - Fee Related
- 2002-01-21 DK DK02703564T patent/DK1355906T3/da active
- 2002-01-21 IL IL15706502A patent/IL157065A0/xx unknown
- 2002-01-21 DE DE60202590T patent/DE60202590T2/de not_active Expired - Lifetime
- 2002-01-21 WO PCT/EP2002/000567 patent/WO2002059113A1/en active IP Right Grant
- 2002-01-21 SI SI200230096T patent/SI1355906T1/xx unknown
- 2002-01-21 AU AU2002237282A patent/AU2002237282B2/en not_active Ceased
- 2002-01-21 ES ES02703564T patent/ES2236485T3/es not_active Expired - Lifetime
- 2002-01-21 CN CNB02804066XA patent/CN1261431C/zh not_active Expired - Fee Related
- 2002-01-21 MX MXPA03006505A patent/MXPA03006505A/es active IP Right Grant
- 2002-01-21 NZ NZ527144A patent/NZ527144A/en unknown
- 2002-01-21 EP EP02703564A patent/EP1355906B1/en not_active Expired - Lifetime
- 2002-01-21 CZ CZ20032014A patent/CZ20032014A3/cs unknown
- 2002-01-21 SK SK939-2003A patent/SK287086B6/sk not_active IP Right Cessation
- 2002-01-21 DZ DZ023459A patent/DZ3459A1/fr active
- 2002-01-21 PL PL02365062A patent/PL365062A1/xx not_active IP Right Cessation
- 2002-01-21 PT PT02703564T patent/PT1355906E/pt unknown
- 2002-01-21 HU HU0401018A patent/HUP0401018A3/hu unknown
- 2002-01-21 CA CA002435775A patent/CA2435775A1/en not_active Abandoned
- 2002-01-21 JP JP2002559415A patent/JP4332349B2/ja not_active Expired - Fee Related
- 2002-01-21 BR BR0207066-9A patent/BR0207066A/pt not_active IP Right Cessation
2003
- 2003-07-08 TN TNPCT/EP2002/000567A patent/TNSN03043A1/en unknown
- 2003-07-15 MA MA27236A patent/MA26982A1/fr unknown
- 2003-07-23 IL IL157065A patent/IL157065A/en not_active IP Right Cessation
- 2003-07-23 NO NO20033318A patent/NO327808B1/no not_active IP Right Cessation
2004
- 2004-04-26 HK HK04102904A patent/HK1060558A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
MA26982A1 (fr)	2004-12-20
NZ527144A (en)	2005-03-24
EP1355906B1 (en)	2005-01-12
DZ3459A1 (fr)	2002-08-01
CN1261431C (zh)	2006-06-28
US20040106595A1 (en)	2004-06-03
JP4332349B2 (ja)	2009-09-16
EA006158B1 (ru)	2005-10-27
PL365062A1 (en)	2004-12-27
BR0207066A (pt)	2004-03-30
DK1355906T3 (da)	2005-05-30
IL157065A (en)	2010-05-17
SK287086B6 (sk)	2009-11-05
CA2435775A1 (en)	2002-08-01
EA200300727A1 (ru)	2004-02-26
AU2002237282B2 (en)	2007-02-15
NO20033318L (no)	2003-09-24
SK9392003A3 (en)	2003-12-02
SI1355906T1 (en)	2005-06-30
DE60202590T2 (de)	2005-12-29
CZ20032014A3 (cs)	2003-12-17
CN1487934A (zh)	2004-04-07
WO2002059113A1 (en)	2002-08-01
HK1060558A1 (en)	2004-08-13
IL157065A0 (en)	2004-02-08
HUP0401018A3 (en)	2007-05-29
DE60202590D1 (de)	2005-02-17
MXPA03006505A (es)	2004-04-21
US6951883B2 (en)	2005-10-04
JP2004517151A (ja)	2004-06-10
EP1355906A1 (en)	2003-10-29
NO327808B1 (no)	2009-09-28
PT1355906E (pt)	2005-05-31
ES2236485T3 (es)	2005-07-16
ATE286894T1 (de)	2005-01-15
HUP0401018A2 (hu)	2004-09-28
TNSN03043A1 (en)	2005-12-23

Legal Events

Date	Code	Title	Description
2010-08-23	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
WO2003080582A3 (de)	2004-12-09	Fredericamycin-derivate
MXPA03010134A (es)	2004-03-10	Derivados de ciclohexan-1-4-diamina sustituidos.
NL300305I1 (nl)	2008-01-02	Werkwijze voor de bereiding van gesubstitueerde octanoylamides.
HK1092467A1 (en)	2007-02-09	N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n-
NO20042739L (no)	2004-07-23	Farmasoytiske sammensetninger av 5,6,14-triazatetracyklo(10.3.1.0(2,11).0(4,9))-heksadeca-2(11)3,5,7,9-pentan
MXPA04003636A (es)	2004-07-27	Composiciones farmaceuticas que comprenden acido micofenolico o sal de micofenolato.
TWI268278B (en)	2006-12-11	2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses
NO20033318D0 (no)	2003-07-23	2H-1-benzopyranderivater, fremgangsmåte ved fremstilling samt farmasöytiskesammensetninger derav
MXPA03007635A (es)	2003-12-04	P-tienilbencilamidas que sirven como agonistas de receptores para angiotensina-(1-7), metodo para su produccion, su uso y preparaciones farmaceuticas que las contienen.
WO2003033557A3 (de)	2003-09-18	Fluorhaltige copolymere, deren herstellung und verwendung
WO2001087287A3 (en)	2002-05-16	Use of pyrazole derivatives for treating infertility
WO2003037863A3 (de)	2004-08-12	Substituierte indole, verfahren zu deren herstellung und deren verwendung zur schmerzbekämpfung
DK1118610T3 (da)	2002-12-16	Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne
MXPA04004090A (es)	2004-07-08	Compuestos substituidos de 1h-quinolin-2-ona.
HK1065305A1 (en)	2005-02-18	Substituted 4-aminocyclohexanol derivatives
AP2001002369A0 (en)	2001-12-31	Pharmaceutical complex.
ATE286893T1 (de)	2005-01-15	2h-1-benzopyran-derivative, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
IT1289154B1 (it)	1998-09-29	Derivati di isoflavone loro preparazione e loro impiego terapeutico
MXPA05009428A (es)	2005-12-12	Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas.
EP1436279B8 (en)	2008-10-29	Chemical compounds
HUP0402283A3 (en)	2009-07-28	Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine, process for their preparation and pharmaceutical compositions containing them
CA2420056A1 (en)	2002-03-28	1-amino-alkylcyclohexanes as trypanocidal agents
WO2003064394A8 (de)	2003-12-24	5-ring heterozyklen zur verwendung als antiviral mittel
MXPA03008636A (es)	2003-12-08	Derivados de isoquinuclidina, metodo para fabricar los mismos y agentes terapeuticos que contienen estos compuestos.
ZA200308097B (en)	2004-10-18	Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes.